NCT02245451View on ClinicalTrials.gov

Study of Tipranavir and Ritonavir on the Pharmacokinetic Characteristics of Methadone Administered in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

February 28, 2005

Conditions
Healthy
Interventions
DRUG

Tipranavir

DRUG

Ritonavir

DRUG

Methadone

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02245451 - Study of Tipranavir and Ritonavir on the Pharmacokinetic Characteristics of Methadone Administered in Healthy Volunteers | Biotech Hunter | Biotech Hunter